SCRS Talks

Holdback payments evolved as a way for industry sponsors and CROs to ensure that their clinical research sites were completing the necessary work throughout a trial. However, holdback payments have been a long-standing issue for sites.  Vivienne van de Walle, co-founder of PreCare Trial & Recruitment, shares lessons learned from working with sponsors and CROs to eliminate this practice, and ti...

The industry is currently facing unprecedented macroeconomic issues including substantial staffing challenges and inflationary pressures.  In response, SCRS formed a task force committee , which provides resources for both sites and industry to collaborate to address these issues. David Vulcano, SCRS Honorary President and VP of Clinical Research Compliance & Integrity at HCA Healthcare speaks...

In this episode of SCRS Talks, we spoke with Jane Myles, VP of Clinical Trial Innovation at Curebase , a new Global Impact Partner. Jane shares what research sites should know about decentralized trial technology and some initiatives Curebase is working on that will impact sites.

Join SCRS in welcoming Clinical ink to the Global Impact Partner (GIP) program! Syed Faridi, Senior Director of Business Development, and Lane Nichols, Executive Vice President, Head of Product, share why they decided to become a GIP and what they see for the future of their relationship with clinical research sites.

This Clinical Trials Day is especially meaningful to SCRS because it is the same day as SCRS' first-ever Diversity Site Solutions Summit.   To share a preview of some of the critical discussions that we'll cover at the Summit, we are joined by Lorena Kuri from Bristol Myers Squibb, Lloryn Hubbard from PPD, and Jaleeysa King from Greenphire. We'll highlight some of the industry'...

Please join us in welcoming Aspen Insights to the SCRS Global Impact Partner program! Walter Storm, co-founder and CEO of Aspen Insights shares how his organization is listening to sites to understand their pain points and developing solutions to resolve them using data analytics. Listen to hear some initiatives Aspen Insights is working on to support site sustainability and streamlined trial enro...

In this episode, SCRS is excited to showcase H1 , one of SCRS' newest Global Impact Partners . We spoke with Adam Wyckoff, Director of Product Management, Clinical Trials, who shares why H1 believes listening to site voices is important and how they plan to work more closely with research sites in the future.  For more information about H1, please reach out to H1 at elizabeth.schwartz@h1.co.

SCRS is celebrating 10 years since our founder, Christine K. Pierre, officially formed the organization! We spoke with Clare Grace, Chief Patient Officer at one of SCRS' first Global Impact Partners , Parexel , to look back on why SCRS was created and how it has evolved through the years. We also explore current industry challenges SCRS is working to address, including how prioritizing site s...

In January 2022, the U.S. enacted legislation supporting our industry’s ability to sponsor more diverse, equitable, and inclusive clinical trials via the Clinical Treatment Act.  This law aims to create equal and increased access to clinical trials for more than 76 million Americans enrolled in Medicaid. SCRS sat down with Scott Gray, CEO of Clincierge , who shares more insight into this new law a...

Comprised of experienced and committed executives representing different segments of the clinical research industry, the SCRS Leadership Council provides strategic guidance, policy decisions and oversight to SCRS. Our newest Leadership Council member Mohammad A. Millwala, CEO of DM Clinical Research , shares how he initially became involved with SCRS,  industry initiatives he is excited to work on...

In this episode, we're discussing a new U.S. law condition that states Medicaid is to cover the trial-related routine care costs for Medicaid beneficiaries in clinical trials. Effective January 2022, there is a new form for principal investigators to use in these instances to secure Medicaid coverage, creating an additional and potentially burdensome step for research sites and patients with...

In February 2022, the Diverse and Equitable Participation in Clinical Trials (DEPICT) Act was submitted to legislation. Kim Kundert, Sr. Vice President of Site Development Services at Total Diversity Clinical Trial Management, joins us to discuss how the industry can prepare for upcoming changes surrounding diverse patient participation in clinical research. Learn more about the DEPICT Act: https:...

As many organizations within the clinical research industry search for candidates, many want to work with those they already know. Unfortunately, this means some CROs and sponsors are asking site staff to come and work for their organizations instead.  Karri Venn, Chief Operating Officer, President, and Chair of the Operating Board at Centricity Research discusses her experience with site staff po...

Collaborating with other sites can expand your site's opportunities and revenue significantly when done right. Kay Scroggins, Steve Satek, and Ana Marquez discuss why they founded their new site network, Flourish Research , and advice they have for other sites looking to expand, sell or collaborate with one another. Find out how your site can grow through partnerships in this episode.

Jackie Kent, Chief Customer Officer at Medidata , a Dassault Systèmes company, shares background on the SCRS Diversity Awareness Program and takeaways from hosting diversity-focused discussions with sites, patients, and industry partners. What strategies are working, and what can we expect next to ensure better diversity in clinical trials? Listen to this episode to learn more and be sure to join...

What does receiving the SCRS Eagle Award mean for the clinical research industry and the organizations that receive it? SCRS sits down with Liz Rogers, Vice President, Head of Global Site and Study Operations at Pfizer , the 2021 Eagle Award recipient, to hear what receiving the award means to Pfizer. Rogers also shares some insight into what Pfizer will be working on over the next year and a spec...

Supporting site sustainability is the #1 priority for SCRS and its Global Impact Partners . Silvina Baudino, Director, Site Engagement, shares why Teckro recently became an SCRS Global Impact Partner, and some initiatives their organization is working on that will impact clinical research sites. Learn more about Teckro and what this new relationship means for SCRS and its site community!

Rodrigo Garcia, MD, MS, Vice President of Patient Solutions at PPD , part of Thermo Fisher Scientific, sits down with SCRS to discuss what receiving the 2021 Eagle Award means to PPD and the industry, some takeaways from the 2021 Global Site Solutions Summit, and a preview from what to expect from PPD over the next few years. Learn more about the SCRS Eagle Awards: https://sitesolutionssummit.com/

Sandy Smith, Senior Vice President of Clinical Solutions and Strategic Partnering at WCG Clinical and SCRS Global Oncology Summit Chair shares what she is most excited about for this year's Oncology Summit, including some of the hot topics we will cover at the Summit. Learn what attendees can expect from the Summit and how to maximize your experience! Learn more about the Global Oncology Summ...

Meet SCRS' new Honorary President, David Vulcano, as we discuss what this new role means to him and SCRS. David shares his vision for the future of our organization and the clinical research industry as we look ahead to SCRS initiatives for 2022.

Tune in as Steven Geller, PhD, Medical Director at Centennial Medical Group, shows you the patient recruitment strategy that earned the 2021 SCRS Site Patient Recruitment Innovation Award (SPRIA), which celebrates one site that has demonstrated innovation in its patient enrollment. Dr. Geller also shares insights on industry recruitment challenges and how sites can achieve and exceed enrollment go...

What does it mean for sites to be patient-centric? Learn from Ellen Price, Director of Patient Engagement at Meridian Clinical Research, the recipient of the 2021 Excellence in Patient Centricity Award. Ellen walks us through the programs that grew her organization despite the challenges of COVID-19 and how other sites can establish consistent patient-centric practices. Learn more about the SCRS E...

The Christine K. Pierre Site Impact Award recognizes an industry leader who has made tremendous contributions to the site community through their dedication, actions and innovation. They exemplify the mission of SCRS to unify the voice of the global clinical research site community for greater site sustainability and uphold the pillars of SCRS by supporting the education, advocacy, mentorship and...

We sit down with Stacey Bledsoe, the Advisor for Clinical Trial Diversity at Eli Lilly and Company (Lilly) to talk about what is being done in the industry to advance diversity in clinical trials. Stacey touches specifically on some of the work Lilly is doing, as well as diving specifically into the Oncology therapeutic area. The needs of this community are different, yet just as important as othe...

Kay Scroggins, President and CEO of Clinical Trials of Texas and the SCRS 2021 Global Site Solutions Summit chair shares what she is most excited about for this year’s Global Summit in Hollywood, Florida. Tune in as we discuss can’t-miss sessions and how attendees can maximize their experience at the Summit.